Benatar M, Wuu J, Andersen PM, Atassi N, David W, Cudkowicz M, Schoenfeld D. Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology. 2018 Feb 13;90(7):e565-e574. Epub 2018 Jan 24. [PubMed Link]
Recent Posts
- Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation
- UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies
- ALS Center investigators host first international Pre-Symptomatic ALS Workshop
- CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant
- Phase III Trial Evaluating Arimoclomol for ALS Patients Reaches Full Enrollment
Recent Comments